In addition, the presence of a FET::CREB fusion itself may not be enough to place a tumor to the methylation class “intracranial mesenchymal tumor”, as what happened to Cases 3 and 4 in our cohort. This evidence concerns the gene CREB1 and mesenchymal cell neoplasm.